14 research outputs found
Cancer Genes Hypermethylated in Human Embryonic Stem Cells
Developmental genes are silenced in embryonic stem cells by a bivalent histone-based chromatin mark. It has been proposed that this mark also confers a predisposition to aberrant DNA promoter hypermethylation of tumor suppressor genes (TSGs) in cancer. We report here that silencing of a significant proportion of these TSGs in human embryonic and adult stem cells is associated with promoter DNA hypermethylation. Our results indicate a role for DNA methylation in the control of gene expression in human stem cells and suggest that, for genes repressed by promoter hypermethylation in stem cells in vivo, the aberrant process in cancer could be understood as a defect in establishing an unmethylated promoter during differentiation, rather than as an anomalous process of de novo hypermethylation
A pre-tRNA carrying intron features typical of Archaea is spliced in yeast
Archaeal pre-tRNAs are characterized by the presence of the bulgeâhelixâbulge (BHB) structure in the intron stem-and-loop region. A chimeric pre-tRNA was constructed bearing an intron of the archaeal type and the mature domain of the Saccharomyces cerevisiae suppressor SUP4 tRNA(Tyr). This pre-tRNA(ArchEuka) is correctly cleaved in several cell-free extracts and by purified splicing endonucleases. It is also cleaved and ligated in S. cerevisiae cells, providing efficient suppression of nonsense mutations in various genes
MicroRNA-based promotion of human neuronal differentiation and subtype specification.
MicroRNAs are key regulators of neural cell proliferation, differentiation and fate choice. Due to the limited access to human primary neural tissue, the role of microRNAs in human neuronal differentiation remains largely unknown. Here, we use a population of long-term self-renewing neuroepithelial-like stem cells (lt-NES cells) derived from human embryonic stem cells to study the expression and function of microRNAs at early stages of human neural stem cell differentiation and neuronal lineage decision. Based on microRNA expression profiling followed by gain- and loss-of-function analyses in lt-NES cells and their neuronal progeny, we demonstrate that miR-153, miR-324-5p/3p and miR-181a/a contribute to the shift of lt-NES cells from self-renewal to neuronal differentiation. We further show that miR-125b and miR-181a specifically promote the generation of neurons of dopaminergic fate, whereas miR-181a inhibits the development of this neurotransmitter subtype. Our data demonstrate that time-controlled modulation of specific microRNA activities not only regulates human neural stem cell self-renewal and differentiation but also contributes to the development of defined neuronal subtypes
Reciprocal Regulation between Bifunctional miR-9/9â and its Transcriptional Modulator Notch in Human Neural Stem Cell Self-Renewal and Differentiation
Tight regulation of the balance between self-renewal and differentiation of neural stem cells is crucial to assure proper neural development. In this context, Notch signaling is a well-known promoter of stemness. In contrast, the bifunctional brain-enriched microRNA miR-9/9â has been implicated in promoting neuronal differentiation. Therefore, we set out to explore the role of both regulators in human neural stem cells. We found that miR-9/9â decreases Notch activity by targeting NOTCH2 and HES1, resulting in an enhanced differentiation. Vice versa, expression levels of miR-9/9â depend on the activation status of Notch signaling. While Notch inhibits differentiation of neural stem cells, it also induces miR-9/9â via recruitment of the Notch intracellular domain (NICD)/RBPj transcriptional complex to the miR-9/9â_2 genomic locus. Thus, our data reveal a mutual interaction between bifunctional miR-9/9â and the Notch signaling cascade, calibrating the delicate balance between self-renewal and differentiation of human neural stem cells
Analysis of microRNA expression in human ES cells, lt-NES cells and derived neural progeny.
<p>(<b>A</b>) Phase contrast image of a human ES cell colony (I3 line). (<b>B</b>â<b>D</b>) Immunofluorescent images of, respectively, self-renewing lt-NES cells stained for the neural precursor marker Nestin (<b>B</b>), and lt-NES cell cultures differentiated for 15 days (ND15; <b>C</b>), and 30 days (ND30; <b>D</b>), stained for the pan-neuronal marker β-III tubulin. DAPI labels nuclei. Scale barsâ=â100 Âľm. (<b>E</b>) Heat-map showing a hierarchical clustering of miRNA expression profiles in lt-NES cells (NES) and ND15 and ND30 differentiated neuronal cultures, compared to human ES cells (I3 ES, used as baseline). Relative expression levels in NES, ND15 and ND30 are displayed as log2 ratios compared to hES cells (yellow, expression increases; blue, expression decreases; ânsâ stays for no significant expression). Representative miRNAs for the different expression groups identified are shown enlarged. In bold are indicated the newly identified neural-associated miRNAs further studied in this work. Abbreviations: DAPI, 4â˛,6-diamidino-2-phenylidole; ES, embryonic stem cells; lt-NES, long-term self-renewing neuroepithelial-like stem cells.</p
Validation of the identified microRNA expression patterns in two different cell lines.
<p>(<b>A</b>â<b>D</b>) Northern blot analyses showing expression of miRNAs in human ES cells (ES), lt-NES cells (NES) and lt-NES cells differentiated for 15 days (ND15) and 30 days (ND30) from the I3 and H9.2 cell lines. Representative miRNAs for the different expression groups identified are shown (Group 1, <b>A</b>; Group 2, <b>B</b>; Group 3, <b>C</b>). (<b>D</b>) Northern blot analyses showing expression of miR-181a and miR-181a* in the samples described above. Putative miRNA precursors are indicated by âpreâ; mature miRNAs are indicated by âmiRâ. U6 snRNA was used as loading control. (<b>E, F</b>) qRT-PCR analyses monitoring expression of miR-153, miR-324-5p, miR-324-3p, miR-181a and miR-181a* in the samples described above from the I3 (<b>E</b>) and H9.2 (<b>F</b>) cell lines. Data are normalized to RNU5A snRNA reference levels and presented as average changes + SEM relative to expression in NES (baseline, set to 1; nâ=â3; *, pâ¤0.05; **, pâ¤0.005; ***, pâ¤0.0001). Abbreviations: ES, embryonic stem cells; lt-NES, long-term self-renewing neuroepithelial-like stem cells; qRT-PCR, quantitative real-time reverse transcription-polymerase chain reaction; snRNA, small nuclear RNA.</p
MiR-124, miR-125b and miR-181a/a*affect subspecification of lt-NES cell-derived neurons.
<p>(<b>A</b>, <b>B</b>) Immunostainings for β-III tubulin plus TH <b>(A)</b> or GAD65/67 (<b>B</b>) in lt-NES cells (I3 cell line) transduced with LVTHM-ctr or LVTHM-miR-124, -miR-125b and -miR-181a/a*, respectively, and differentiated for 15 days. Scale bars â=â100 Âľm. (<b>C</b>, <b>D</b>) Histograms showing the fold change in the number of TH-positive neurons (<b>C</b>) and GAD65/67-positive neurons (<b>D</b>) relative to the number of β-III tubulin-positive neurons in lt-NES cells transduced with LVTHM-ctr or LVTHM-miR-124, -miR-125b, -miR-153, -miR-181a/a* and -miR-324-5p/3p, compared to untransduced cells (equal to 1, dashed line). Data are presented as mean + SEM (nâ=â3; **, pâ¤0.01). (<b>E</b>) qRT-PCR analyses of NURR1, DAT, TH and GAD1 expression in 15 days differentiated lt-NES cell cultures overexpressing LVTHM-ctr, -miR-124, -miR-125b, and -miR-181a/a*, respectively. Data are normalized to 18S rRNA reference levels and presented as average changes + SEM relative to expression levels in LVTHM-ctr transduced lt-NES cells (equal to 1, nâĽ3; *, pâ¤0.05; **, pâ¤0.01; ***, pâ¤0.0001). Abbreviations: ctr, control; DAT, dopamine transporter; GAD, glutamic acid decarboxylase; lt-NES, long-term self-renewing neuroepithelial-like stem cells; NURR1, Nuclear receptor related 1 protein; qRT-PCR, quantitative real-time reverse transcription-polymerase chain reaction; rRNA, ribosomal RNA; TH, tyrosine-hydroxylase.</p
Transient modulation of microRNA activities impacts neuronal lineage development.
<p>(<b>A</b>, <b>B</b>) Histograms showing the percentage of β-III tubulin-positive cells in 7 days (<b>A</b>, ND7) and 15 days (<b>B</b>, ND15) differentiated lt-NES cells (I3 cell line) transfected with control (ctr), miR-124, miR-125b, miR-181a and miR-181a* mimics and inhibitors. (<b>C</b>) Histogram showing the percentage of TH-positive neurons in lt-NES cells transfected as described above and differentiated for 15 days. Data in <b>A</b>â<b>C</b> are presented as mean + SEM (nâ=â3; *, pâ¤0.05; **, pâ¤0.01; ***, pâ¤0.0001). (<b>D</b>) Representative immunostainings for β-III tubulin and TH in 15 days differentiated lt-NES cells transfected with ctr, miR-181a mimic or miR-181a* inhibitor. DAPI labels nuclei. Scale barâ=â100 Âľm. (<b>E</b>) Histogram showing the percentage of TH-positive neurons in lt-NES cells differentiated for 15 days under default conditions (default) or in presence of factors that promote dopaminergic neuron differentiation (DN-factors). Data are presented as mean + SEM (nâ=â3; *, pâ¤0.05). (<b>F</b>) Histogram showing the ratio of miR-181a versus miR-181a* expression in lt-NES cells differentiated under default conditions or in presence of DN-factors, as assessed by qRT-PCR analysis. Data are normalized to RNU5A snRNA reference levels and are presented as mean + SEM (nâ=â3; ***, pâ¤0.0001). (<b>G</b>) Histogram showing the ratio of miR-181a versus miR-181a* expression in human fetal whole brain and in human fetal midbrain extracts, as assessed by qRT-PCR analysis. Data are normalized to miR-16 reference levels and presented as mean + SEM (nâ=â2). (<b>H</b>, <b>I</b>) Histograms showing the percentages of β-III tubulin-positive cells (<b>H</b>) and TH-positive (<b>I</b>) neurons in lt-NES cultures differentiated in presence of DN-inducing factors and transfected with miRNA mimics. The percentage of immunopositive cells in the mock-transfection controls in <b>A</b>â<b>C, H</b> and <b>I</b> is indicated by dashed lines. Abbreviations: ctr, control; DAPI, 4â˛,6-diamidino-2-phenylidole; DN, dopamine neuron, lt-NES, long-term self-renewing neuroepithelial-like stem cells; qRT-PCR, quantitative real-time reverse transcription-polymerase chain reaction; snRNA, small nuclear RNA; TH, tyrosine-hydroxylase.</p